Study of single nucleotide polymorphisms of FBW7 and its substrate genes revealed a predictive factor for paclitaxel plus cisplatin chemotherapy in Chinese patients with advanced esophageal squamous cell carcinoma

Paclitaxel plays a major role in the treatment of advanced esophageal squamous cell carcinoma. However, there is no biomarker that could be used to predict the clinical response of paclitaxel. This work was conducted to investigate the association of genetic polymorphisms in FBW7 and its substrate g...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ying, Xu, Shu Ning, Chen, Yong Shun, Wu, Xiao Yuan, Qiao, Lei, Li, Ke, Yuan, Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190100/
https://www.ncbi.nlm.nih.gov/pubmed/27259248
http://dx.doi.org/10.18632/oncotarget.9736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190100/
https://www.ncbi.nlm.nih.gov/pubmed/27259248
http://dx.doi.org/10.18632/oncotarget.9736

Ejemplares similares